GL1X · GenesisL1 explorer

Research workbench

Structure of active human M2 muscarinic acetylcholine receptor bound to the agonist iperoxo

Analyse Structure of active human M2 muscarinic acetylcholine receptor bound to the… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4MQS
Type
protein
Length
398 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Muscarinic acetylcholine receptor M2; Nanobody 9-8
UniProt
P08172
Ligands
IXO
Pockets
4 · best druggability 0.76

Structure

x-ray diffraction · 2 distinct chains · 57% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMuscarinic acetylcholine receptor M2protein27779% helix, 0% strandP08172
BNanobody 9-8protein1217% helix, 50% strand—

Ligands and binding sites

  • IXO · 4-(4,5-dihydro-1,2-oxazol-3-yloxy)-N,N,N-trimethylbut-2-yn-1-aminium · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1730.760.9917IXO
23920.700.8237empty
31960.520.7729empty
4680.370.7817empty

Interfaces

1 interface between chains.

  • A–B · 844 Ų buried · 3 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 3 disulfide (disulfide).

Compared structures

  • 4MQS · Structure of active human M2 muscarinic acetylcholine receptor bound to the agonist… · the same entry in another collection · chain A against A, TM-score 1.00
  • P08172 · AlphaFold monomer V2.0 prediction for muscarinic acetylcholine receptor M2 (P08172) · a predicted model of the same protein · chain A against A, TM-score 0.92

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.